Log in Register
Menu

Anti-ADAM17, Polyclonal [17MOPRO]

Invented by Prof Carl Blobel at Hospital For Special Surgery At Weill Cornell Medicine

Info

Catalogue Number 152542
Applications WB
Antigen/Gene or Protein Targets ADAM17
Reactivity Mouse
Relevance ADAM17 (TACE/CD156b) has proved capable of cleaving epidermal growth factor receptor (EGFR) ligands, extracellular Notch1, cell-surface receptors, and adhesion molecules. As proteolytic cleavage is an indispensable activation event for many of these substrates, ADAM17 has emerged as an attractive therapeutic target for the treatment of cancer and rheumatoid arthritis.
Host Rabbit
Immunogen Pro-domain of murine ADAM17
Formulation Whole serum
Molecular Weight (kDa) ~120
Notes Suggested dilution for western blot: 1:250
Research Area Cancer, Cell Signaling & Signal Transduction, Metabolism, Neurobiology, Stem Cell Biology

References: 1 entry

Schlöndorff et al. 2000. Biochem J. 347 Pt 1:131-8. PMID: 10727411.


Add a reference

References: 1 entry

Schlöndorff et al. 2000. Biochem J. 347 Pt 1:131-8. PMID: 10727411.


Add a reference

References: 1 entry

Schlöndorff et al. 2000. Biochem J. 347 Pt 1:131-8. PMID: 10727411.


Add a reference


This reagent does not have any reviews at the moment.